Ponesimod
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 149 publications
Uncoupling Relapse Reduction and Disability Progression: Evidence From Tolebrutinib Studies.
Journal: Neurology. Clinical practice
Published: May 11, 2026
The impact of age on efficacy and safety of disease modifying treatment-insights from the Austrian Multiple Sclerosis Treatment Registry.
Journal: Journal of neurology
Published: March 14, 2026
Effects of Sphingosine 1-phosphate Modulators on Central Remyelination: A Systematic Review of Animal Models.
Journal: Cellular and molecular neurobiology
Published: February 11, 2026
Cost-effectiveness of treatment sequences following first-line rituximab in relapsing-remitting multiple sclerosis: a Norwegian microsimulation study.
Journal: Frontiers in neurology
Published: January 08, 2026
Effect of Sphingosine-1-Phosphate Receptor Modulators on Insulin Resistance: A Review.
Journal: The Annals of pharmacotherapy
Published: January 03, 2026
The comparative efficacy of cladribine tablets versus alternative disease-modifying treatments for relapsing-remitting multiple sclerosis: Updated meta-regression estimates by patient subgroup.
Journal: Multiple sclerosis and related disorders
Published: December 20, 2025
Disease-modifying treatment for multiple sclerosis in Poland in a European context: current practices and therapeutic strategies.
Journal: Neurologia i neurochirurgia polska
Published: December 18, 2025
Comparative effectiveness of anti-CD20 therapies and S1P receptor modulators in late-onset multiple sclerosis: real-world evidence from the MSBase registry.
Journal: Therapeutic advances in neurological disorders
Published: November 09, 2025
Long-term safety and efficacy of ponesimod in participants with relapsing multiple sclerosis: results from the phase 3 OPTIMUM 5-year long term extension study.
Journal: Journal of neurology
Published: November 03, 2025
Efficacy and safety of disease-modifying oral drugs in treatment of relapsing-remitting multiple sclerosis: systematic review and network meta-analysis.
Journal: Frontiers in immunology
Published: October 28, 2025
Last Updated: 06/30/2026